Access 2.8M+ Filings Sign Up Free
Epigenomics AG Logo

Epigenomics AG | ECX - Profile, Filings, Stock Info & Investor Relations Data

Epigenomics AG | ECX
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Health Care Equipment & Supplies
Country
Germany
Founded
1998
Epigenomics AG (ECX)

Company Profile

Website
Investor Relations

About Epigenomics AG

We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need. Using blood as a liquid biopsy can improve patient access to cancer screening and thereby contribute to eradicate today’s deadliest cancer types such as colorectal, liver, and lung cancer. By leveraging our product pipeline and strong intellectual property, we aim to become a global leader in blood-based cancer detection.

Employees

32

Market Presence

Worldwide

Headquarters

Bertha-Benz-Str. 5
10557, Berlin
Germany

Epigenomics AG (ECX)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Epigenomics AG (ECX)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Ho, Dr. Selwyn (Board)
Buy EUR 4,200.00 EUR 2.10 27.12.22
↑
von Prondzynski, Heino (Supervisory board)
Buy EUR 5,625.00 EUR 0.38 23.12.22
◆
Ahlers, Felix (Board)
Other EUR 22,000.00 EUR 55.00 22.12.22
↑
Lubenow, Dr. Helge (Supervisory board)
Buy EUR 1,934.20 EUR 0.39 22.12.22
↑
von Prondzynski, Heino (Supervisory board)
Buy EUR 3,680.00 EUR 0.37 20.12.22
↑
Lindenice GmbH (Board)
Buy EUR 7,400.00 EUR 3.40 16.12.22
↑
Ho, Dr. Selwyn (Board)
Buy EUR 6,780.00 EUR 2.26 16.12.22
↑
von Prondzynski, Heino (Supervisory board)
Buy EUR 40,000.00 EUR 0.40 14.12.22

Epigenomics AG (ECX)
Stock & Investor Information

ISINs

DE000A37FT41
DE000A3E5UB2
US29428N3008

LEI

549300X1C4U862NDLN97

Designated Sponsor

Pareto Securities

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies